Drug Biotransformation / Drug Metabolism
Definition
Biotransformation is the enzymatic chemical alteration of a drug (xenobiotic) within the body, usually converting a lipid-soluble, non-polar drug into a more polar, water-soluble metabolite that can be eliminated through urine or bile.
Exam buzz words:
Enzymatic conversion - lipophilic to hydrophilic - functionalization - conjugation - detoxification - bioinactivation - active/toxic metabolite - renal/biliary excretion.
It does not always mean inactivation. Metabolism may produce:
- Inactive metabolite: chloramphenicol
- Active metabolite: diazepam → desmethyldiazepam
- Toxic metabolite: paracetamol → NAPQI
- Active drug from prodrug: enalapril → enalaprilat; codeine → morphine
The principal organ is the liver, especially the smooth endoplasmic reticulum (microsomal enzymes) of hepatocytes. Other sites: intestinal mucosa, kidney, lungs, plasma, skin, and brain. Lipophilic drugs would otherwise be reabsorbed from renal tubules and persist in the body. Katzung's Basic & Clinical Pharmacology, 16th ed., p. 93.
Pictorial Diagram: Overall Pathway
Write this flowchart in the exam
LIPID-SOLUBLE DRUG
│
│ (may be directly excreted if already polar)
▼
┌───────────────────────────────────────────┐
│ PHASE I: FUNCTIONALIZATION REACTIONS │
│ Oxidation / Reduction / Hydrolysis │
│ Introduces or unmasks: -OH, -NH2, -SH, -COOH│
└───────────────────────────────────────────┘
│
┌────────────────┼───────────────────┐
│ │ │
▼ ▼ ▼
Inactive metabolite Active metabolite Reactive/toxic
│ e.g., codeine metabolite
│ → morphine e.g., NAPQI
▼
Excretion if sufficiently polar
│
▼
OR
│
▼
┌───────────────────────────────────────────┐
│ PHASE II: CONJUGATION / SYNTHETIC REACTIONS│
│ Glucuronidation, sulfation, acetylation, │
│ methylation, glutathione, amino-acid │
└───────────────────────────────────────────┘
│
▼
HIGHLY POLAR, WATER-SOLUBLE CONJUGATE
│
▼
URINE / BILE / FECES
Important point: A drug need not undergo Phase I before Phase II. Drugs having groups such as -OH, -NH₂, or -COOH may undergo direct conjugation. Example: morphine and lorazepam undergo direct glucuronidation. Also, Phase II can occasionally precede Phase I, as with isoniazid. Katzung's Basic & Clinical Pharmacology, 16th ed., p. 93.
Mechanisms of Drug Metabolism
Classification at a Glance
| Type | Reactions | Main site / enzymes | Main result |
|---|
| Phase I | Oxidation, reduction, hydrolysis | Mainly microsomal CYP450 system | Functional group introduced/unmasked |
| Phase II | Conjugation / synthetic reactions | Microsomal or cytosolic transferases | Highly polar conjugate formed |
| Microsomal metabolism | Mostly oxidation, glucuronidation | Smooth ER of liver | Inducible; inhibited; subject to genetic polymorphism |
| Non-microsomal metabolism | Hydrolysis, acetylation, sulfation, methylation etc. | Cytoplasm, mitochondria, plasma, tissues | Usually not induced by drugs |
I. Phase I Reactions: Functionalization Reactions
Definition
These reactions introduce or expose a polar functional group such as:
-OH -NH2 -SH -COOH
They generally make a drug more polar and prepare it for Phase II conjugation.
Main reactions
PHASE I = OXIDATION + REDUCTION + HYDROLYSIS
Most Phase I oxidation occurs through the microsomal cytochrome P450 mixed-function oxidase system.
A. Oxidation
1. Cytochrome P450-dependent microsomal oxidation
This is the commonest mechanism of drug metabolism.
Location: Smooth endoplasmic reticulum of hepatocytes, called the microsomal fraction.
Components of CYP450 mixed-function oxidase system
NADPH
│
▼
NADPH-CYP450 reductase
│
▼
Cytochrome P450 (haemoprotein)
│
▼
O2 + Drug (RH)
│
▼
Oxidized drug (ROH) + H2O
General reaction
RH + O2 + NADPH + H+
CYP450
────────────────────→ ROH + H2O + NADP+
Why called mixed-function oxidase / monooxygenase?
One atom of oxygen is incorporated into the drug, while the other atom is reduced to water.
Important CYP450 isoenzymes
| Isoenzyme | High-yield examples of drugs metabolized |
|---|
| CYP3A4/5 | Midazolam, cyclosporine, statins, erythromycin, many drugs |
| CYP2D6 | Codeine, metoprolol, tricyclic antidepressants |
| CYP2C9 | Warfarin, phenytoin, NSAIDs |
| CYP2C19 | Diazepam, omeprazole, clopidogrel |
| CYP1A2 | Theophylline, caffeine |
| CYP2E1 | Ethanol, paracetamol bioactivation |
Types of oxidative reactions with examples
| Oxidative reaction | Example |
|---|
| Aromatic hydroxylation | Phenytoin, warfarin, propranolol |
| Aliphatic hydroxylation | Pentobarbital, ibuprofen |
| N-dealkylation | Diazepam, imipramine, morphine derivatives |
| O-dealkylation | Codeine → morphine |
| S-dealkylation | Methitural |
| N-oxidation | Nicotine, imipramine |
| S-oxidation | Chlorpromazine, cimetidine |
| Oxidative deamination | Amphetamine |
| Desulfuration | Thiopental; parathion → paraoxon |
| Epoxidation | Carbamazepine; aromatic hydrocarbons |
Katzung lists aromatic and aliphatic hydroxylation, epoxidation, N/O/S-dealkylation, N-oxidation, S-oxidation, deamination, desulfuration, and dechlorination among CYP450-dependent oxidations. Katzung's Basic & Clinical Pharmacology, 16th ed., Chapter 4.
High-scoring examples
Codeine ──CYP2D6 O-dealkylation──► Morphine (active metabolite)
Diazepam ──CYP3A4 N-dealkylation / hydroxylation──► Active metabolites
──glucuronidation──► Excretion
Paracetamol ──CYP2E1──► NAPQI (toxic reactive metabolite)
──Glutathione──► Non-toxic conjugate
2. Non-microsomal oxidation
Occurs in mitochondria, cytoplasm, plasma, and other tissues. It is mediated by enzymes such as:
- Alcohol dehydrogenase
- Aldehyde dehydrogenase
- Monoamine oxidase
- Xanthine oxidase
| Enzyme | Example |
|---|
| Alcohol dehydrogenase | Ethanol → acetaldehyde |
| Aldehyde dehydrogenase | Acetaldehyde → acetate |
| Monoamine oxidase | Catecholamines, tyramine |
| Xanthine oxidase | 6-mercaptopurine metabolism |
B. Reduction
Reduction occurs in the microsomes and non-microsomal sites, especially when oxygen tension is low.
Types and examples
| Reaction | Example |
|---|
| Azo reduction | Prontosil → sulfanilamide |
| Nitro reduction | Chloramphenicol; nitrazepam |
| Carbonyl reduction | Chloral hydrate → trichloroethanol |
| Disulfide reduction | Disulfiram metabolites |
| Reductive dehalogenation | Halothane metabolism |
Exam line: Reduction is less common than oxidation but is important for drugs containing azo, nitro, and carbonyl groups.
C. Hydrolysis
Definition
Hydrolysis is cleavage of a drug molecule by addition of water, mediated by esterases, amidases, peptidases, and phosphatases.
Sites
- Liver
- Plasma
- Intestinal mucosa
- Kidney
- Other tissues
Examples
| Drug / compound | Hydrolytic product / enzyme |
|---|
| Procaine | Hydrolysed by plasma pseudocholinesterase |
| Succinylcholine | Hydrolysed by plasma pseudocholinesterase |
| Aspirin | Hydrolysed to salicylic acid |
| Atropine | Ester hydrolysis |
| Lidocaine | Amide hydrolysis, mainly hepatic |
| Enalapril | Hydrolysed to active enalaprilat |
| Heroin | Hydrolysed to morphine |
Buzz words:
Ester drugs are rapidly hydrolysed by esterases, whereas amide-linked drugs are comparatively stable and mainly undergo hepatic metabolism.
II. Phase II Reactions: Conjugation / Synthetic Reactions
Definition
Phase II reactions involve covalent coupling of the drug or its Phase I metabolite with an endogenous, highly polar substrate.
Result
Drug / Phase I metabolite
+
Endogenous conjugating moiety
│
▼
Highly polar conjugate
│
▼
Urinary or biliary excretion
Usually, conjugation causes inactivation and detoxification, but exceptions exist. Certain conjugation products can be reactive or toxic, including N-acetylation of isoniazid and some glucuronide conjugates. Katzung's Basic & Clinical Pharmacology, 16th ed., Chapter 4.
Major Phase II Reactions
| Reaction | Donor / cofactor | Enzyme | Important examples |
|---|
| Glucuronidation | UDP-glucuronic acid | UDP-glucuronosyl transferase | Morphine, paracetamol, chloramphenicol, lorazepam |
| Sulfation | PAPS | Sulfotransferase | Paracetamol, methyldopa, steroid hormones |
| Acetylation | Acetyl-CoA | N-acetyltransferase | Isoniazid, hydralazine, procainamide, sulfonamides |
| Methylation | S-adenosyl methionine | Methyltransferase | Adrenaline, noradrenaline, histamine, 6-mercaptopurine |
| Glutathione conjugation | Glutathione | Glutathione-S-transferase | NAPQI from paracetamol |
| Amino acid conjugation | Glycine / glutamine etc. | Acyl transferase | Salicylic acid + glycine → salicyluric acid |
A. Glucuronidation
Key facts
- Most common Phase II reaction
- Donor: UDP-glucuronic acid (UDPGA)
- Enzyme: UDP-glucuronosyl transferase (UGT)
- Mainly occurs in hepatic microsomes
- Forms water-soluble glucuronides, excreted in urine or bile.
Examples
Morphine ──► Morphine glucuronide
Paracetamol ──► Paracetamol glucuronide
Chloramphenicol ──► Chloramphenicol glucuronide
Lorazepam ──► Lorazepam glucuronide
Clinical relevance:
Neonates have deficient glucuronidation. Chloramphenicol may accumulate and cause gray baby syndrome.
B. Acetylation
Key facts
- Donor: Acetyl-CoA
- Enzyme: N-acetyltransferase
- Site: Mainly cytoplasm of liver
- Includes genetic polymorphism, producing slow acetylators and fast acetylators.
Examples
Isoniazid
Hydralazine
Procainamide
Sulfonamides
Dapsone
Clinical importance of slow acetylators
| Drug | Consequence in slow acetylator |
|---|
| Isoniazid | Peripheral neuropathy, hepatotoxicity |
| Hydralazine | Drug-induced lupus erythematosus |
| Procainamide | Lupus-like syndrome |
Exam buzz words:
NAT2 polymorphism - fast acetylator - slow acetylator - pharmacogenetic variation.
C. Sulfation
- Donor: PAPS: 3′-phosphoadenosine-5′-phosphosulfate
- Enzyme: Sulfotransferase
- Usually occurs in the cytosol.
Examples
- Paracetamol
- Methyldopa
- Steroid hormones
- Phenolic drugs
D. Methylation
- Donor: S-adenosyl methionine (SAM)
- Enzyme: Methyltransferase
- In contrast to most conjugations, methylation may not markedly increase water solubility.
Examples
Noradrenaline / adrenaline ──COMT──► methylated metabolites
Histamine ──► methylhistamine
6-mercaptopurine ──TPMT──► methylated metabolite
Clinical point: TPMT deficiency can cause severe myelotoxicity with thiopurines.
E. Glutathione Conjugation
- Endogenous substrate: Reduced glutathione (GSH)
- Enzyme: Glutathione-S-transferase
- Role: Detoxifies electrophilic reactive metabolites.
Classic example: Paracetamol
Paracetamol
├── Glucuronidation / sulfation ──► non-toxic metabolites
│
└── CYP2E1 ──► NAPQI (toxic electrophilic metabolite)
│
├── GSH conjugation ──► non-toxic excretion
│
└── In overdose: GSH depleted
│
▼
Hepatic necrosis
Antidote: N-acetylcysteine, which replenishes glutathione.
F. Amino Acid Conjugation
Examples:
Salicylic acid + glycine ──► Salicyluric acid
Benzoic acid + glycine ──► Hippuric acid
Microsomal Versus Non-microsomal Drug Metabolism
| Feature | Microsomal metabolism | Non-microsomal metabolism |
|---|
| Location | Smooth ER, mainly liver | Cytoplasm, mitochondria, plasma, tissues |
| Major enzymes | CYP450, UGT | Esterases, amidases, MAO, alcohol dehydrogenase, NAT |
| Main reactions | Oxidation, some reduction, glucuronidation | Hydrolysis, acetylation, sulfation, methylation, oxidation |
| Drug induction | Present | Usually absent |
| Drug inhibition | Present | Usually absent/minimal |
| Genetic polymorphism | Important | Important for some enzymes, e.g., NAT2, TPMT |
| Examples | Warfarin, diazepam, phenytoin | Procaine, succinylcholine, isoniazid, ethanol |
Final Exam Conclusion
Biotransformation is a protective metabolic process that converts lipid-soluble drugs into more polar metabolites for elimination. It occurs predominantly in the liver and comprises:
PHASE I = Oxidation + Reduction + Hydrolysis
PHASE II = Conjugation / Synthetic reactions
However, metabolism can also lead to:
Bioinactivation → chloramphenicol
Bioactivation → enalapril to enalaprilat
Active metabolite → codeine to morphine
Toxic metabolite → paracetamol to NAPQI
The two most examinable take-home lines are:
- “Phase I reactions introduce or unmask a functional group, whereas Phase II reactions conjugate the drug with an endogenous polar moiety.”
- “Drug metabolism usually detoxifies and facilitates excretion, but may also activate prodrugs or generate active and toxic metabolites.”